§ Funding Round
Series A funding round for Delix Therapeutics raising $70M in September 2021
Series A funding round for Delix Therapeutics raising $70M in September 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | vasudev bailey | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
OMX VenturesLEAD | Organization | — |
Palo Santo | — | — |
| Organization | — | |
| Organization | — | |
andrew levinLEAD | Angel | andrew levin |
| Organization | — | |
Saya Bio | — | — |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$110M
Top Valuation
-
Delix Therapeutics raised $70M in a Series A round.
The round was announced on 09/01/21.
The round was led by OMX Ventures, andrew levin.
